G. Martins, K. Calame, E. Cubedo, M. Maurin, X. Jiang et al., 534 BCL6 programs lymphoma cells for survival and differentiation through distinct 535 biochemical mechanisms, Regulation and functions of Blimp-1 in T and B 528 lymphocytes, vol.26, pp.133-69, 2007.

J. Zhang, S. Vlasevska, V. A. Wells, S. Nataraj, A. B. Holmes et al., , vol.538

, Crebbp Acetyltransferase is a Haploinsufficient Tumor Suppressor in B Cell, vol.539

. Lymphoma, Cancer discovery, vol.540, p.12, 2017.

L. Pasqualucci, D. Dominguez-sola, A. Chiarenza, G. Fabbri, A. Grunn et al., Bereshchenko OR, Gu W, Dalla-Favera R. Acetylation inactivates the 544 transcriptional repressor BCL6, Nature genetics, vol.471, issue.7337, p.14, 2002.

C. Pangault, A. , P. Ruminy, P. Rossille, D. Caron et al.,

, Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent 548

, B cell axis, Leukemia, vol.24, issue.12, p.15, 2010.

A. , L. Priol, J. Yssel, H. Caron, G. Pangault et al., 550 Characterization of intratumoral follicular helper T cells in follicular lymphoma: 551 role in the survival of malignant B cells, Leukemia, vol.26, issue.5, p.16, 2012.

R. Kuppers, Mechanisms of B-cell lymphoma pathogenesis, Nature reviews 554 Cancer, vol.5, issue.4, p.17, 2005.

H. Kretzmer, S. H. Bernhart, W. Wang, A. Haake, M. A. Weniger et al., DNA methylome analysis in Burkitt and follicular lymphomas identifies 557 differentially methylated regions linked to somatic mutation and transcriptional 558 control, Nature genetics, vol.559, p.18, 2015.

O. I. Koues, R. A. Kowalewski, L. W. Chang, S. C. Pyfrom, J. A. Schmidt et al.,

, Enhancer sequence variants and transcription-factor deregulation synergize to 561 construct pathogenic regulatory circuits in B-cell lymphoma, Immunity, vol.562, issue.1, p.19, 2015.

Y. Jiang, A. Ortega-molina, H. Geng, H. Y. Ying, K. Hatzi et al., CREBBP 564 Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. 565 Cancer discovery, vol.7, 2017.

M. R. Green, S. Kihira, C. L. Liu, R. V. Nair, R. Salari et al., Mutations in 567 early follicular lymphoma progenitors are associated with suppressed antigen 568 presentation, Proceedings of the National Academy of Sciences of the United, vol.569, p.21, 2015.

F. Morschhauser, L. Terriou, B. Coiffier, E. Bachy, A. Varga et al., Phase 571 1 study of the oral histone deacetylase inhibitor abexinostat in patients with 572 Hodgkin lymphoma, non-Hodgkin lymphoma, p.573